This writer still recalls the thrill of being gifted their first fountain pen upon moving into high school. “The fountain pen still has a place of pride among collectors,” reveals Nisha Singhi. It is ...

Two private companies are partnering up to establish a repeatable debris removal service for low Earth orbit. The U.S. firm Portal Space Systems and Australian startup Paladin Space are working ...

'All Rhodes' will be produced by Magilla Entertainment, the banner behind 'Moonshiners' and 'Beachfront Bargain Hunt.' By Tony Maglio Brandi Rhodes is getting a new reality show, All Rhodes, courtesy ...

NEW YORK CITY (PIX11) — New York City is taking another step toward the mayor’s pledge to make child care more accessible, with a major shift coming to its 2‑K program that could ease costs for ...

The global economy has become dependent on the AI industry. Trillions of dollars are being invested into the technology and the infrastructure it relies on; in the final months of 2025, functionally ...

LOS ANGELES, March 25 (Reuters) - Stephen Colbert is heading to Middle‑earth. The comedian announced in a video posted Tuesday that following the end of his 11‑year run as host of CBS's "The Late Show ...

Stephen Colbert is going on an unexpected journey. The comedian has announced a surprising new gig for after "The Late Show" ends in May: He's set to write a new film in the "Lord of the Rings" ...

The film will come after 'Lord of the Rings: Hunt for Gollum,' which is currently in development from director Andy Serkis. By Carly Thomas Senior Editor, Digital “And I started talking it over with ...

The Texas Comptroller's Office has approved two Islamic private schools from North Texas to take part in the state's taxpayer‑funded school choice program. The move comes one day after Houston federal ...

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing ...

This transcript was created using speech recognition software. While it has been reviewed by human transcribers, it may contain errors. Please review the episode audio before quoting from this ...